253 related articles for article (PubMed ID: 29383665)
21. Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.
Awad MM; Johanesen PA; Carter GP; Rose E; Lyras D
Gut Microbes; 2014; 5(5):579-93. PubMed ID: 25483328
[TBL] [Abstract][Full Text] [Related]
22. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G
Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616
[TBL] [Abstract][Full Text] [Related]
23. Sequence variation in tcdA and tcdB of Clostridium difficile: ST37 with truncated tcdA is a potential epidemic strain in China.
Du P; Cao B; Wang J; Li W; Jia H; Zhang W; Lu J; Li Z; Yu H; Chen C; Cheng Y
J Clin Microbiol; 2014 Sep; 52(9):3264-70. PubMed ID: 24958798
[TBL] [Abstract][Full Text] [Related]
24. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.
Hirota SA; Iablokov V; Tulk SE; Schenck LP; Becker H; Nguyen J; Al Bashir S; Dingle TC; Laing A; Liu J; Li Y; Bolstad J; Mulvey GL; Armstrong GD; MacNaughton WK; Muruve DA; MacDonald JA; Beck PL
Infect Immun; 2012 Dec; 80(12):4474-84. PubMed ID: 23045481
[TBL] [Abstract][Full Text] [Related]
25. The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins.
Chen S; Sun C; Wang H; Wang J
Toxins (Basel); 2015 Dec; 7(12):5254-67. PubMed ID: 26633511
[TBL] [Abstract][Full Text] [Related]
26. Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria.
Schwan C; Stecher B; Tzivelekidis T; van Ham M; Rohde M; Hardt WD; Wehland J; Aktories K
PLoS Pathog; 2009 Oct; 5(10):e1000626. PubMed ID: 19834554
[TBL] [Abstract][Full Text] [Related]
27. Human α-Defensin-6 Neutralizes
Barthold L; Heber S; Schmidt CQ; Gradl M; Weidinger G; Barth H; Fischer S
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562899
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Clostridium difficile TcdA and TcdB toxins with transition state analogues.
Paparella AS; Aboulache BL; Harijan RK; Potts KS; Tyler PC; Schramm VL
Nat Commun; 2021 Nov; 12(1):6285. PubMed ID: 34725358
[TBL] [Abstract][Full Text] [Related]
29. Use of a neutralizing antibody helps identify structural features critical for binding of
Kroh HK; Chandrasekaran R; Rosenthal K; Woods R; Jin X; Ohi MD; Nyborg AC; Rainey GJ; Warrener P; Spiller BW; Lacy DB
J Biol Chem; 2017 Sep; 292(35):14401-14412. PubMed ID: 28705932
[No Abstract] [Full Text] [Related]
30. Domestic canines do not display evidence of gut microbial dysbiosis in the presence of Clostridioides (Clostridium) difficile, despite cellular susceptibility to its toxins.
Stone NE; Nunnally AE; Jimenez V; Cope EK; Sahl JW; Sheridan K; Hornstra HM; Vinocur J; Settles EW; Headley KC; Williamson CHD; Rideout JR; Bolyen E; Caporaso JG; Terriquez J; Monroy FP; Busch JD; Keim P; Wagner DM
Anaerobe; 2019 Aug; 58():53-72. PubMed ID: 30946985
[TBL] [Abstract][Full Text] [Related]
31. Comparative genomic analysis of toxin-negative strains of Clostridium difficile from humans and animals with symptoms of gastrointestinal disease.
Roy Chowdhury P; DeMaere M; Chapman T; Worden P; Charles IG; Darling AE; Djordjevic SP
BMC Microbiol; 2016 Mar; 16():41. PubMed ID: 26971047
[TBL] [Abstract][Full Text] [Related]
32. Toxin B is essential for virulence of Clostridium difficile.
Lyras D; O'Connor JR; Howarth PM; Sambol SP; Carter GP; Phumoonna T; Poon R; Adams V; Vedantam G; Johnson S; Gerding DN; Rood JI
Nature; 2009 Apr; 458(7242):1176-9. PubMed ID: 19252482
[TBL] [Abstract][Full Text] [Related]
33. Novel one-step method for detection and isolation of active-toxin-producing Clostridium difficile strains directly from stool samples.
Darkoh C; Dupont HL; Kaplan HB
J Clin Microbiol; 2011 Dec; 49(12):4219-24. PubMed ID: 21976761
[TBL] [Abstract][Full Text] [Related]
34. On the Potential Significance of the Intrinsically Disordered Regions in the Clostridiodes difficile Toxins A and B.
El Hadidy N; Uversky VN; Sun X
Curr Protein Pept Sci; 2022 Jul; 23(3):192-209. PubMed ID: 35585826
[TBL] [Abstract][Full Text] [Related]
35. Toward a structural understanding of Clostridium difficile toxins A and B.
Pruitt RN; Lacy DB
Front Cell Infect Microbiol; 2012; 2():28. PubMed ID: 22919620
[TBL] [Abstract][Full Text] [Related]
36. Toxin-producing Clostridium difficile strains as long-term gut colonizers in healthy infants.
Adlerberth I; Huang H; Lindberg E; Åberg N; Hesselmar B; Saalman R; Nord CE; Wold AE; Weintraub A
J Clin Microbiol; 2014 Jan; 52(1):173-9. PubMed ID: 24172156
[TBL] [Abstract][Full Text] [Related]
37. Multicentre study of the prevalence of toxigenic Clostridium difficile in Korea: results of a retrospective study 2000-2005.
Shin BM; Kuak EY; Yoo HM; Kim EC; Lee K; Kang JO; Whang DH; Shin JH
J Med Microbiol; 2008 Jun; 57(Pt 6):697-701. PubMed ID: 18480325
[TBL] [Abstract][Full Text] [Related]
38. Tolevamer, an anionic polymer, neutralizes toxins produced by the BI/027 strains of Clostridium difficile.
Hinkson PL; Dinardo C; DeCiero D; Klinger JD; Barker RH
Antimicrob Agents Chemother; 2008 Jun; 52(6):2190-5. PubMed ID: 18391047
[TBL] [Abstract][Full Text] [Related]
39. Clostridium difficile Toxin A Undergoes Clathrin-Independent, PACSIN2-Dependent Endocytosis.
Chandrasekaran R; Kenworthy AK; Lacy DB
PLoS Pathog; 2016 Dec; 12(12):e1006070. PubMed ID: 27942025
[TBL] [Abstract][Full Text] [Related]
40. High metabolic versatility of different toxigenic and non-toxigenic Clostridioides difficile isolates.
Riedel T; Wetzel D; Hofmann JD; Plorin SPEO; Dannheim H; Berges M; Zimmermann O; Bunk B; Schober I; Spröer C; Liesegang H; Jahn D; Overmann J; Groß U; Neumann-Schaal M
Int J Med Microbiol; 2017 Sep; 307(6):311-320. PubMed ID: 28619474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
